{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:36:02Z","timestamp":1786649762632,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>\n                    Infertility, defined as an inability to get pregnant following 12 months of regular, unprotected intercourse, is a significant problem, and 15% is unexplained. Autoimmune conditions such as anti-phospholipid syndrome (APS) and systemic lupus erythematosus cause infertility by altering implantation by thrombophilic mechanisms and immune derangement. Despite progress in assisted reproductive technologies, implantation failure continues to be a strong hindrance, determined by maternal health, immune tolerance and endometrial receptivity. Antiphospholipid antibodies (aPLs) compromise trophoblast function, enhance thrombosis risk and account for\n                    <jats:italic toggle=\"yes\">in vitro<\/jats:italic>\n                    fertilisation (IVF) failure, recurrent pregnancy loss and pregnancy complications. A review of 45 peer-reviewed articles published over the past 8 years was performed on PubMed, Scopus, Web of Science and Google Scholar. MeSH terms used were \u2018antiphospholipid syndrome\u2019, \u2018in vitro fertilization\u2019, and \u2018infertility\u2019. Non-English publications, case reports, editorials and conference abstracts were not included. Results suggest that APS and aPL inhibit implantation due to trophoblast malfunction, inflammation and thrombosis, causing infertility and recurrent pregnancy loss. In IVF, aPL correlates with reduced rates of implantation and live birth, with various subtypes of antibodies predicting adverse outcomes. Traditional therapies such as low-dose aspirin and low-molecular-weight heparin are routine, whereas novel therapies such as intravenous immunoglobulin, rituximab and eculizumab hold promise for resistant disease. Due to the inconclusive effect of aPL on IVF success, individualised risk stratification and focused anticoagulation regimens are important for maximising reproductive outcomes.\n                  <\/jats:p>","DOI":"10.4103\/npmj.npmj_112_25","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:01:28Z","timestamp":1767337288000},"page":"151-155","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Antiphospholipid Antibodies in In vitro Fertilisation: Pathogenesis, Implantation Failure and Emerging Therapeutic Strategies"],"prefix":"10.4103","volume":"33","author":[{"given":"Ananya","family":"Parida","sequence":"first","affiliation":[{"name":"Department of Clinical Embryology, School of Allied Health Sciences, Datta Meghe Institute of Higher Education and Research, Nagpur, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Nair","sequence":"additional","affiliation":[{"name":"Department of Clinical Embryology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajasi","family":"Sengupta","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Datta Meghe Medical College, Datta Meghe Institute of Higher Education and Research, Nagpur, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarya","family":"Lele","sequence":"additional","affiliation":[{"name":"Department of Clinical Embryology, School of Allied Health Sciences, Datta Meghe Institute of Higher Education and Research, Nagpur, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"R1-20260420","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.2021.4788","article-title":"Diagnosis and management of infertility: A review","volume":"326","author":"Carson","year":"2021","journal-title":"JAMA"},{"key":"R2-20260420","first-page":"1","article-title":"Investigating the Genetic basis of unexplained infertility and potential chromosomal abnormalities","volume":"8","author":"Mega Obukohwo","year":"2024","journal-title":"OBM Genet"},{"key":"R4-20260420","first-page":"194","article-title":"The ICSI procedure from past to future: A systematic review of the more controversial aspects","volume":"22","author":"Rubino","year":"2016","journal-title":"Hum Reprod Update"},{"key":"R5-20260420","first-page":"76","article-title":"Impact of various parameters as predictors of the success rate of in vitro fertilization","volume":"16","author":"Dabbagh Rezaeiyeh","year":"2022","journal-title":"Int J Fertil Steril"},{"issue":"1","key":"R6-20260420","first-page":"e0416","article-title":"The prevalence of antiphospholipid antibodies and effects on the outcomes of in vitro fertilization","volume":"7","author":"Halki","year":"2024","journal-title":"Int J Surg Glob Health"},{"key":"R8-20260420","first-page":"1650","article-title":"Clinical trial of a novel benzodiazepine derivative in a double-blind study using the Wittenborn psychiatric rating scale (author\u2019s transl)]","volume":"25","author":"Husser","year":"1975","journal-title":"Arzneimittelforschung"},{"key":"R9-20260420","doi-asserted-by":"crossref","first-page":"103101","DOI":"10.1016\/j.autrev.2022.103101","article-title":"Antiphospholipid antibodies in women with recurrent embryo implantation failure: A systematic review and meta-analysis","volume":"21","author":"Jarne-Borr\u00e0s","year":"2022","journal-title":"Autoimmun Rev"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"e0260759","DOI":"10.1371\/journal.pone.0260759","article-title":"Presence of antiphospholipid antibodies is associated with increased implantation failure following in vitro fertilization technique and embryo transfer: A systematic review and meta-analysis","volume":"17","author":"Papadimitriou","year":"2022","journal-title":"PLoS One"},{"key":"R12-20260420","doi-asserted-by":"crossref","first-page":"e13470","DOI":"10.1111\/aji.13470","article-title":"Antiphospholipid antibodies and pregnancy outcome of assisted reproductive treatment: A systematic review and meta-analysis","volume":"86","author":"Gao","year":"2021","journal-title":"Am J Reprod Immunol"},{"key":"R13-20260420","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1055\/s-0044-1790225","article-title":"Impact of antiphospholipid syndrome on reproductive outcomes: Current insights and management approaches","volume":"42","author":"He","year":"2024","journal-title":"Semin Reprod Med"},{"key":"R14-20260420","first-page":"102301","article-title":"Antiphospholipid antibodies levels and potential effects on in-vitro fertilization in a large cohort of infertile Syrian women","volume":"65","author":"Deeb","year":"2021","journal-title":"Ann Med Surg (Lond)"},{"key":"R15-20260420","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1055\/s-0039-1697982","article-title":"Antiphospholipid antibody syndrome and infertility","volume":"41","author":"Rodrigues","year":"2019","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"Suppl 1","key":"R16-20260420","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/ijlh.14268","article-title":"Noncriteria antiphospholipid antibodies in antiphospholipid syndrome","volume":"46","author":"Devreese","year":"2024","journal-title":"Int J Lab Hematol"},{"key":"R17-20260420","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11926-018-0772-y","article-title":"Obstetric anti-phospholipid syndrome: State of the art","volume":"20","author":"Gerardi","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"R18-20260420","doi-asserted-by":"crossref","first-page":"49","DOI":"10.37897\/RJR.2023.2.4","article-title":"Consequences of antiphospholipid syndrome in pregnancy-A review","volume":"32","author":"Gashi","year":"2023","journal-title":"Ro J Rheumatol"},{"key":"R19-20260420","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3390\/jcm14030733","article-title":"Antiphospholipid syndrome: A comprehensive clinical review","volume":"14","author":"Patriarcheas","year":"2025","journal-title":"J Clin Med"},{"key":"R20-20260420","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3390\/jcm13030741","article-title":"Platelets and thrombotic antiphospholipid syndrome","volume":"13","author":"Tohidi-Esfahani","year":"2024","journal-title":"J Clin Med"},{"key":"R21-20260420","doi-asserted-by":"crossref","first-page":"102437","DOI":"10.1016\/j.jaut.2020.102437","article-title":"Antiphospholipid antibodies can specifically target placental mitochondria and induce ROS production","volume":"111","author":"Zussman","year":"2020","journal-title":"J Autoimmun"},{"key":"R22-20260420","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/25785826.2021.1969116","article-title":"Obstetric anti-phospholipid syndrome: From pathogenesis to treatment","volume":"45","author":"Kaneko","year":"2022","journal-title":"Immunol Med"},{"key":"R23-20260420","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s13317-011-0017-9","article-title":"Pathophysiology of the antiphospholipid antibody syndrome","volume":"2","author":"Willis","year":"2011","journal-title":"Autoimmun Highlights"},{"key":"R24-20260420","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.3389\/fimmu.2019.01609","article-title":"Environmental triggers of autoreactive responses: Induction of antiphospholipid antibody formation","volume":"10","author":"Martirosyan","year":"2019","journal-title":"Front Immunol"},{"key":"R26-20260420","doi-asserted-by":"crossref","first-page":"986893","DOI":"10.3389\/fimmu.2022.986893","article-title":"Anticardiolipin and\/or anti-\u03b22-glycoprotein-I antibodies are associated with adverse IVF outcomes","volume":"13","author":"Wu","year":"2022","journal-title":"Front Immunol"},{"key":"R27-20260420","doi-asserted-by":"crossref","first-page":"101912","DOI":"10.1016\/j.jogoh.2020.101912","article-title":"Anti-phospholipid antibody may reduce endometrial receptivity during the window of embryo implantation","volume":"50","author":"Tan","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"R28-20260420","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.3390\/biomedicines11102681","article-title":"Trophoblast cell function in the antiphospholipid syndrome","volume":"11","author":"Vrzi\u0107 Petronijevi\u0107","year":"2023","journal-title":"Biomedicines"},{"key":"R31-20260420","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.3346\/jkms.2021.36.e24","article-title":"Management of women with antiphospholipid antibodies or antiphospholipid syndrome during pregnancy","volume":"36","author":"Lee","year":"2021","journal-title":"J Korean Med Sci"},{"key":"R33-20260420","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.autrev.2015.11.009","article-title":"Intravenous immunoglobulins and antiphospholipid syndrome: How, when and why? A review of the literature","volume":"15","author":"Tenti","year":"2016","journal-title":"Autoimmun Rev"},{"key":"R36-20260420","doi-asserted-by":"crossref","first-page":"11","DOI":"10.17749\/2313-7347.2017.11.3.011-019","article-title":"Use of intravenous immunoglobulin within the IVF\/ICSI protocol in women with infertility and antiphospholipid antibodies","volume":"11","author":"Krivonos","year":"2017","journal-title":"Obstet Gynecol Reprod"},{"key":"R37-20260420","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.fertnstert.2018.05.009","article-title":"The role of immunotherapy in in vitro fertilization: A guideline","volume":"110","author":"Penzias","year":"2018","journal-title":"Fertil Steril"},{"key":"R39-20260420","doi-asserted-by":"crossref","first-page":"rkaf005","DOI":"10.1093\/rap\/rkaf005","article-title":"Navigating antiphospholipid syndrome: From personalized therapies to cutting-edge research","volume":"9","author":"Kortright-Maldonado","year":"2025","journal-title":"Rheumatol Adv Pract"},{"key":"R40-20260420","doi-asserted-by":"crossref","first-page":"108597","DOI":"10.1016\/j.clim.2020.108597","article-title":"Treatment of antiphospholipid syndrome","volume":"221","author":"Radin","year":"2020","journal-title":"Clin Immunol"},{"key":"R41-20260420","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tmrv.2022.09.002","article-title":"Emerging therapies in antiphospholipid syndrome","volume":"36","author":"Hubben","year":"2022","journal-title":"Transfus Med Rev"}],"container-title":["Nigerian Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/npmj.npmj_112_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:58:08Z","timestamp":1786647488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/npmj.npmj_112_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/npmj.npmj_112_25","relation":{},"ISSN":["1117-1936","2468-6875"],"issn-type":[{"value":"1117-1936","type":"print"},{"value":"2468-6875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-03-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}